COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes?
The DisCoVeRy clinical trial aimed at the evaluation of four treatments for patients suffering from severe to critical COVID-19: Hydroxychloroquine, eventually associated with azithromycin; the combination lopinavir/ritonavir; the combination with the addition of interferon β-1a; remdesivir. The tri...
Saved in:
Main Author: | Jean Jacques Vanden Eynde (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial
by: Noémie Mercier, et al.
Published: (2023) -
COVID-19: An Update about the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020) -
COVID-19: A Brief Overview of the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020) -
Diş hekimliğinde estetik ve renk
by: Erkut Kahramanoğlu, et al.
Published: (2013) -
Diş hekimliğinde estetik ve renk
by: Erkut Kahramanoğlu, et al.
Published: (2012)